-
1
-
-
67349258581
-
The present and future burden of urinary bladder cancer in the world
-
Ploeg, M., Aben, K. K. & Kiemeney, L. A. The present and future burden of urinary bladder cancer in the world. World J. Urol. 27, 289-293 (2009).
-
(2009)
World J. Urol.
, vol.27
, pp. 289-293
-
-
Ploeg, M.1
Aben, K.K.2
Kiemeney, L.A.3
-
2
-
-
77955635233
-
Cancer statistics 2010
-
Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300 (2010).
-
(2010)
CA Cancer J. Clin.
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
3
-
-
0346100499
-
The health economics of bladder cancer: A comprehensive review of the published literature
-
Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B. & Hauser, R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21, 1315-1330 (2003).
-
(2003)
Pharmacoeconomics
, vol.21
, pp. 1315-1330
-
-
Botteman, M.F.1
Pashos, C.L.2
Redaelli, A.3
Laskin, B.4
Hauser, R.5
-
4
-
-
33748925553
-
Clinical model of lifetime cost of treating bladder cancer and associated complications
-
Avritscher, E. B. et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 68, 549-553 (2006).
-
(2006)
Urology
, vol.68
, pp. 549-553
-
-
Avritscher, E.B.1
-
5
-
-
45849140589
-
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
-
Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303-314 (2008).
-
(2008)
Eur. Urol.
, vol.54
, pp. 303-314
-
-
Babjuk, M.1
-
6
-
-
32944465832
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466-477 (2006).
-
(2006)
Eur. Urol.
, vol.49
, pp. 466-477
-
-
Sylvester, R.J.1
-
7
-
-
67651092245
-
Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy
-
Van Rhijn, B. W. et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur. Urol. 56, 430-442 (2009).
-
(2009)
Eur. Urol.
, vol.56
, pp. 430-442
-
-
Van Rhijn, B.W.1
-
8
-
-
36049006136
-
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
-
Hall, M. C. et al. Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update. J. Urol. 178, 2314-2330 (2007).
-
(2007)
J. Urol.
, vol.178
, pp. 2314-2330
-
-
Hall, M.C.1
-
9
-
-
5144224183
-
Focus on bladder cancer
-
Dinney, C. P et al. Focus on bladder cancer. Cancer Cell 6, 111-116 (2004).
-
(2004)
Cancer Cell
, vol.6
, pp. 111-116
-
-
Dinney, C.P.1
-
10
-
-
33644868287
-
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
-
Knowles, M. A. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27, 361-373 (2006).
-
(2006)
Carcinogenesis
, vol.27
, pp. 361-373
-
-
Knowles, M.A.1
-
11
-
-
49749100700
-
Molecular pathogenesis of bladder cancer
-
Knowles, M. A. Molecular pathogenesis of bladder cancer. Int. J. Clin. Oncol. 13, 287-297 (2008).
-
(2008)
Int. J. Clin. Oncol.
, vol.13
, pp. 287-297
-
-
Knowles, M.A.1
-
12
-
-
77953847133
-
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
-
McConkey, D. J. et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol. Oncol. 28, 429-440 (2010).
-
(2010)
Urol. Oncol.
, vol.28
, pp. 429-440
-
-
McConkey, D.J.1
-
13
-
-
34247337239
-
Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification
-
Mitra, A. P, Datar, R. H. & Cote, R. J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J. Clin. Oncol. 24, 5552-5564 (2006).
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 5552-5564
-
-
Mitra, A.P.1
Datar, R.H.2
Cote, R.J.3
-
14
-
-
25444467767
-
Urothelial tumorigenesis: A tale of divergent pathways
-
Wu, X. R. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev. Cancer 5, 713-725 (2005).
-
(2005)
Nat Rev. Cancer
, vol.5
, pp. 713-725
-
-
Wu, X.R.1
-
15
-
-
76649100093
-
Biology of urothelial tumorigenesis: Insights from genetically engineered mice
-
Wu, X. R. Biology of urothelial tumorigenesis: insights from genetically engineered mice. Cancer Metastasis Rev. 28, 281-290 (2009).
-
(2009)
Cancer Metastasis Rev.
, vol.28
, pp. 281-290
-
-
Wu, X.R.1
-
16
-
-
0032521376
-
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
-
Cote, R. J. et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res. 58, 1090-1094 (1998).
-
(1998)
Cancer Res.
, vol.58
, pp. 1090-1094
-
-
Cote, R.J.1
-
17
-
-
0025782858
-
Identification of p53 gene mutations in bladder cancers and urine samples
-
Sidransky, D. et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252, 706-709 (1991).
-
(1991)
Science
, vol.252
, pp. 706-709
-
-
Sidransky, D.1
-
18
-
-
0027979420
-
The Spectrum of TP53 mutations in bladder carcinoma
-
Williamson, M. P., Elder, P. A. & Knowles, M. A. The Spectrum of TP53 mutations in bladder carcinoma. Genes Chromosomes Cancer 9, 108-118 (1994).
-
(1994)
Genes Chromosomes Cancer
, vol.9
, pp. 108-118
-
-
Williamson, M.P.1
Elder, P.A.2
Knowles, M.A.3
-
19
-
-
73749086073
-
Urothelial dysplasia and other flat lesions of the urinary bladder: Clinicopathologic and molecular features
-
Hodges, K. B., Lopez-Beltran, A., Davidson, D. D., Montironi, R. & Cheng, L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum. Pathol. 41 155-162 (2010).
-
(2010)
Hum. Pathol.
, vol.41
, pp. 155-162
-
-
Hodges, K.B.1
Lopez-Beltran, A.2
Davidson, D.D.3
Montironi, R.4
Cheng, L.5
-
20
-
-
0026467220
-
Concurrent mutations of coding and regulatory sequences of the Ha-Ras gene in urinary bladder sarcinomas
-
Czerniak, B. et al. Concurrent mutations of coding and regulatory sequences of the Ha-Ras gene in urinary bladder sarcinomas. Hum. Pathol. 23, 1199-1204 (1992).
-
(1992)
Hum. Pathol.
, vol.23
, pp. 1199-1204
-
-
Czerniak, B.1
-
21
-
-
0020458159
-
Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11
-
Mcbride, O. W. et al. Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. Nature 300, 773-774 (1982).
-
(1982)
Nature
, vol.300
, pp. 773-774
-
-
McBride, O.W.1
-
22
-
-
13444279152
-
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: Contribution of exogenous versus endogenous carcinogens
-
Wallerand, H. et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis 26, 177-184 (2005).
-
(2005)
Carcinogenesis
, vol.26
, pp. 177-184
-
-
Wallerand, H.1
-
23
-
-
0038011950
-
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
-
Van Rhijn, B. W. et al. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J. Clin. Oncol. 21, 1912-1921 (2003).
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 1912-1921
-
-
Van Rhijn, B.W.1
-
24
-
-
36248943079
-
Role of FGFR3 in urothelial cel carcinoma: Biomarker and potential therapeutic target
-
Knowles, M. A. Role of FGFR3 in urothelial cel carcinoma: biomarker and potential therapeutic target. World J. Urol. 25, 581-593 (2007).
-
(2007)
World J. Urol.
, vol.25
, pp. 581-593
-
-
Knowles, M.A.1
-
25
-
-
19944426549
-
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cel growth
-
Gómez-Román, J. J. et al. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cel growth. Clin. Cancer Res. 11, 459-465 (2005).
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 459-465
-
-
Gómez-Román, J.J.1
-
26
-
-
34249775289
-
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours
-
Van Oers, J. M. et al. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Eur. Urol. 52, 760-768 (2007).
-
(2007)
Eur. Urol.
, vol.52
, pp. 760-768
-
-
Van Oers, J.M.1
-
27
-
-
33747079040
-
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
-
Hernández, S. et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J. Clin. Oncol. 24, 3664-3671 (2006).
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 3664-3671
-
-
Hernández, S.1
-
28
-
-
77955508884
-
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer
-
Van Rhijn, B. W. G. et al. Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. Eur. Urol. 58, 433-441 (2010).
-
(2010)
Eur. Urol.
, vol.58
, pp. 433-441
-
-
Van Rhijn, B.W.G.1
-
29
-
-
33747873545
-
PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors
-
López-Knowles, E. et al. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res. 66, 7401-7404 (2006).
-
(2006)
Cancer Res.
, vol.66
, pp. 7401-7404
-
-
López-Knowles, E.1
-
30
-
-
23444440484
-
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
-
Jebar, A. H. et al. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24, 5218-5225 (2005).
-
(2005)
Oncogene
, vol.24
, pp. 5218-5225
-
-
Jebar, A.H.1
-
31
-
-
34548407864
-
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
-
Tomlinson, D. C., Baldo, O., Hamden, P & Knowles, M. A. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J. Pathol. 213, 91-98 (2007).
-
(2007)
J. Pathol.
, vol.213
, pp. 91-98
-
-
Tomlinson, D.C.1
Baldo, O.2
Hamden, P.3
Knowles, M.A.4
-
32
-
-
0027183353
-
Role of chromosome 9 in human bladder cancer
-
Miyao, N. et al. Role of chromosome 9 in human bladder cancer. Cancer Res. 53, 4066-4070 (1993).
-
(1993)
Cancer Res.
, vol.53
, pp. 4066-4070
-
-
Miyao, N.1
-
33
-
-
0033521885
-
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Mplications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer
-
Czerniak, B. et al. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: mplications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 18, 1185-1196 (1999).
-
(1999)
Oncogene
, vol.18
, pp. 1185-1196
-
-
Czerniak, B.1
-
34
-
-
0037734062
-
Bladder neoplasms\regions at chromosome 9 with putative tumour suppressor genes
-
Wada, T. et al. Bladder neoplasms\regions at chromosome 9 with putative tumour suppressor genes. Scand. J. Urol. Nephrol. 37, 106-111 (2003).
-
(2003)
Scand. J. Urol. Nephrol.
, vol.37
, pp. 106-111
-
-
Wada, T.1
-
35
-
-
0034353139
-
Epidemiology and etiology of premalignant and malignant urothelial changes
-
Cohen, S. M., Shirai, T. & Steineck, G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl. 34, 105-115 (2000).
-
(2000)
Scand. J. Urol. Nephrol. Suppl.
, vol.34
, pp. 105-115
-
-
Cohen, S.M.1
Shirai, T.2
Steineck, G.3
-
36
-
-
3042809910
-
The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review
-
Zeegers, M. P, Kellen, E., Buntinx, F & van den Brandt, P A. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J. Urol. 21, 392-401 (2004).
-
(2004)
World J. Urol.
, vol.21
, pp. 392-401
-
-
Zeegers, M.P.1
Kellen, E.2
Buntinx, F.3
Van Den Brandt, P.A.4
-
37
-
-
0019514110
-
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: Carcinogens and carcinogenesis enhancers
-
Clayson, D. B. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: carcinogens and carcinogenesis enhancers. Mutat Res. 86, 217-229 (1981).
-
(1981)
Mutat Res.
, vol.86
, pp. 217-229
-
-
Clayson, D.B.1
-
38
-
-
0031474795
-
Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines
-
Yasunaga, Y. et al. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines. Lab. Invest 77, 677-684 (1997).
-
(1997)
Lab. Invest
, vol.77
, pp. 677-684
-
-
Yasunaga, Y.1
-
39
-
-
14844320585
-
Personal use of hair dyes and the risk of bladder cancer: Results of a meta-analysis
-
Huncharek, M. & Kupelnick, B. Personal use of hair dyes and the risk of bladder cancer: results of a meta-analysis. Public Health Rep. 120, 31-38 (2005).
-
(2005)
Public Health Rep.
, vol.120
, pp. 31-38
-
-
Huncharek, M.1
Kupelnick, B.2
-
40
-
-
0021255603
-
Urinary tract infection and risk of bladder cancer
-
Kantor, A. F et al. Urinary tract infection and risk of bladder cancer. Am. J. Epidemiol. 119, 510-515 (1984).
-
(1984)
Am. J. Epidemiol.
, vol.119
, pp. 510-515
-
-
Kantor, A.F.1
-
41
-
-
0032959297
-
Relationship between schistosomiasis and bladder cancer
-
Mostafa, M. H., Sheweita, S. A. & O'Connor, P J. Relationship between schistosomiasis and bladder cancer. Clin. Microbiol. Rev. 12, 97-111 (1999).
-
(1999)
Clin. Microbiol. Rev.
, vol.12
, pp. 97-111
-
-
Mostafa, M.H.1
Sheweita, S.A.2
O'Connor, P.J.3
-
42
-
-
55049112064
-
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
-
Kiemeney, L. A. et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet. 40, 1307-1312 (2008).
-
(2008)
Nat Genet.
, vol.40
, pp. 1307-1312
-
-
Kiemeney, L.A.1
-
43
-
-
69349100058
-
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
-
Wu, X. et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 41, 991-995 (2009).
-
(2009)
Nat Genet.
, vol.41
, pp. 991-995
-
-
Wu, X.1
-
44
-
-
59149091340
-
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
-
Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 41, 221-227 (2009).
-
(2009)
Nat Genet.
, vol.41
, pp. 221-227
-
-
Rafnar, T.1
-
45
-
-
77951769462
-
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
-
Kiemeney, L. A. et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet. 42, 415-419 (2010).
-
(2010)
Nat Genet.
, vol.42
, pp. 415-419
-
-
Kiemeney, L.A.1
-
46
-
-
0037051091
-
Familial aggregation of urothelial cell carcinoma
-
Aben, K. K. et al. Familial aggregation of urothelial cell carcinoma. Int. J. Cancer 98, 274-278 (2002).
-
(2002)
Int. J. Cancer
, vol.98
, pp. 274-278
-
-
Aben, K.K.1
-
47
-
-
0035913187
-
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
-
Sibley, K., Stern, P & Knowles, M. A. Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours. Oncogene 20, 4416-4418 (2001).
-
(2001)
Oncogene
, vol.20
, pp. 4416-4418
-
-
Sibley, K.1
Stern, P.2
Knowles, M.A.3
-
48
-
-
0035825598
-
Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cel carcinoma
-
Sibley, K., Cuthbert-Heavens, D. & Knowles, M. A. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cel carcinoma. Oncogene 20, 686-691 (2001).
-
(2001)
Oncogene
, vol.20
, pp. 686-691
-
-
Sibley, K.1
Cuthbert-Heavens, D.2
Knowles, M.A.3
-
49
-
-
33747079040
-
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
-
Hernández, S. et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J. Clin. Oncol. 24, 3664-3671 (2006).
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 3664-3671
-
-
Hernández, S.1
-
50
-
-
19744367140
-
Urine markers for bladder cancer surveillance: A systematic review
-
Van Rhijn, B. W., Van der Poel, H. G. & Van der Kwast, T H. Urine markers for bladder cancer surveillance: a systematic review. Eur. Urol. 47, 736-748 (2005).
-
(2005)
Eur. Urol.
, vol.47
, pp. 736-748
-
-
Van Rhijn, B.W.1
Van Der Poel, H.G.2
Van Der Kwast, T.H.3
-
51
-
-
75949121210
-
Molecular screening for bladder cancer: Progress and potential
-
Mitra, A. P & Cote, R. J. Molecular screening for bladder cancer: progress and potential. Nat Rev. Urol. 7, 11-20 (2010).
-
(2010)
Nat Rev. Urol.
, vol.7
, pp. 11-20
-
-
Mitra, A.P.1
Cote, R.J.2
-
52
-
-
62149132464
-
Molecular markers for detection, surveillance and prognostication of bladder cancer
-
Vrooman, O. P & Witjes, J. A. Molecular markers for detection, surveillance and prognostication of bladder cancer. Int. J. Urol. 16, 234-243 (2009).
-
(2009)
Int. J. Urol.
, vol.16
, pp. 234-243
-
-
Vrooman, O.P.1
Witjes, J.A.2
-
53
-
-
0003809054
-
-
Springer-Verlag, New York
-
th edn (Springer-Verlag, New York, 2002).
-
(2002)
th Edn
-
-
Greene, F.L.1
-
55
-
-
33750888342
-
The pathology of bladder cancer: An update on selected issues
-
Pavone-Macaluso, M., Lopez-Beltran, A., Aragona, F., Bassi, P & Fitzpatrick, J. M. The pathology of bladder cancer: an update on selected issues. BJU Int 98, 1161-1165 (2006).
-
(2006)
BJU Int
, vol.98
, pp. 1161-1165
-
-
Pavone-Macaluso, M.1
Lopez-Beltran, A.2
Aragona, F.3
Bassi, P.4
Fitzpatrick, J.M.5
-
56
-
-
0031740494
-
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee
-
Epstein, J. I., Amin, M. B., Reuter, V. R. & Mostofi, F K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22, 1435-1448 (1998).
-
(1998)
Am. J. Surg. Pathol.
, vol.22
, pp. 1435-1448
-
-
Epstein, J.I.1
Amin, M.B.2
Reuter, V.R.3
Mostofi, F.K.4
-
57
-
-
33847095882
-
Histologic grading of noninvasive papillary urothelial neoplasms
-
MacLennan, G. T., Kirkali, Z. & Cheng, L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur. Urol. 51, 889-898 (2007).
-
(2007)
Eur. Urol.
, vol.51
, pp. 889-898
-
-
MacLennan, G.T.1
Kirkali, Z.2
Cheng, L.3
-
58
-
-
0036718575
-
Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: Practical choices for patient care
-
Murphy, W. M., Takezawa, K. & Maruniak, N. A. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. J. Urol. 168, 968-972 (2002).
-
(2002)
J. Urol.
, vol.168
, pp. 968-972
-
-
Murphy, W.M.1
Takezawa, K.2
Maruniak, N.A.3
-
59
-
-
77949491713
-
Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: A multicentre study comparing the 1973 and 2004 world health organisation classifications
-
May, M. et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 world health organisation classifications. Eur. Urol. 57, 850-858 (2010).
-
(2010)
Eur. Urol.
, vol.57
, pp. 850-858
-
-
May, M.1
-
60
-
-
77951622842
-
The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading
-
Rhijn, B. W. et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur. Urol. 57, 1052-1057 (2010).
-
(2010)
Eur. Urol.
, vol.57
, pp. 1052-1057
-
-
Rhijn, B.W.1
-
61
-
-
33751418969
-
Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy
-
Shariat, S. F. et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur. Urol. 51, 137-151 (2007).
-
(2007)
Eur. Urol.
, vol.51
, pp. 137-151
-
-
Shariat, S.F.1
-
62
-
-
77549086840
-
Staging and staging errors in bladder cancer
-
Bostrom, P J. et al. Staging and staging errors in bladder cancer. Eur. Urol. Suppl. 9, 2-9 (2010).
-
(2010)
Eur. Urol. Suppl.
, vol.9
, pp. 2-9
-
-
Bostrom, P.J.1
-
63
-
-
0033786654
-
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials
-
Van Der Meijden, A., Sylvester, R., Collette, L., Bono, A. & Ten Kate, F. The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European organization for research and treatment of cancer trials. J. Urol. 164, 1533-1537 (2000).
-
(2000)
J. Urol.
, vol.164
, pp. 1533-1537
-
-
Van Der Meijden, A.1
Sylvester, R.2
Collette, L.3
Bono, A.4
Ten Kate, F.5
-
64
-
-
0028049182
-
The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial
-
Members of the Dutch South East Cooperative Urological Group
-
Witjes, J. A., Kiemeney, L. A., Schaafsma, H. E. & Debruyne, F. M. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. Br. J. Urol. 73, 172-176 (1994).
-
(1994)
Br. J. Urol.
, vol.73
, pp. 172-176
-
-
Witjes, J.A.1
Kiemeney, L.A.2
Schaafsma, H.E.3
Debruyne, F.M.4
-
65
-
-
33645970703
-
Review pathology in a diagnostic bladder cancer trial: Effect of patient risk category
-
Witjes, J. A., Moonen, P M. J. & van der Heijden, A. G. Review pathology in a diagnostic bladder cancer trial: effect of patient risk category. Urology 67, 751-755 (2006).
-
(2006)
Urology
, vol.67
, pp. 751-755
-
-
Witjes, J.A.1
Moonen, P.M.J.2
Van Der Heijden, A.G.3
-
66
-
-
70350462404
-
Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model
-
Fernandez-Gomez, J. et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J. Urol. 182, 2195-2203 (2009).
-
(2009)
J. Urol.
, vol.182
, pp. 2195-2203
-
-
Fernandez-Gomez, J.1
-
67
-
-
0036586644
-
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies
-
Brausi, M. et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur. Urol. 41, 523-531 (2002).
-
(2002)
Eur. Urol.
, vol.41
, pp. 523-531
-
-
Brausi, M.1
-
68
-
-
34250303107
-
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer
-
Grossman, H. B. et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J. Urol. 178, 62-67 (2007).
-
(2007)
J. Urol.
, vol.178
, pp. 62-67
-
-
Grossman, H.B.1
-
69
-
-
0028551697
-
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
-
Kriegmair, M. et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44, 836-841 (1994).
-
(1994)
Urology
, vol.44
, pp. 836-841
-
-
Kriegmair, M.1
-
70
-
-
0035097699
-
Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer
-
Riedl, C. R. et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J. Urol. 165, 1121-1123 (2001).
-
(2001)
J. Urol.
, vol.165
, pp. 1121-1123
-
-
Riedl, C.R.1
-
71
-
-
0346848832
-
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy
-
Schmidbauer, J. et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy J. Urol. 171, 135-138 (2004).
-
(2004)
J Urol.
, vol.171
, pp. 135-138
-
-
Schmidbauer, J.1
-
72
-
-
77249090657
-
Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis of prospective studies
-
Kausch, I. et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur. Urol. 57, 595-606 (2010).
-
(2010)
Eur. Urol.
, vol.57
, pp. 595-606
-
-
Kausch, I.1
-
73
-
-
0032874440
-
The value of a second transurethral resection in evaluating patients with bladder tumors
-
Herr, H. W. The value of a second transurethral resection in evaluating patients with bladder tumors. J. Urol. 162, 74-76 (1999).
-
(1999)
J. Urol.
, vol.162
, pp. 74-76
-
-
Herr, H.W.1
-
74
-
-
0038152768
-
Effect of routine repeat transurethral resection for superficial bladder cancer: A long-term observational study
-
Grimm, M. O. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J. Urol. 170, 433-437 (2003).
-
(2003)
J. Urol.
, vol.170
, pp. 433-437
-
-
Grimm, M.O.1
-
75
-
-
33646100303
-
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: A prospective, randomized clinical trial
-
Divrik, R. T., Yildirim, U., Zorlu, F. & Ozen, H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J. Urol. 175, 1641-1644 (2006).
-
(2006)
J. Urol.
, vol.175
, pp. 1641-1644
-
-
Divrik, R.T.1
Yildirim, U.2
Zorlu, F.3
Ozen, H.4
-
76
-
-
2442581163
-
P A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
-
Sylvester, R. J., Oosterlinck, W. & van der Meijden, A. P A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials. J. Urol. 171, 2186-2190 (2004).
-
(2004)
J. Urol.
, vol.171
, pp. 2186-2190
-
-
Sylvester, R.J.1
Oosterlinck, W.2
Van Der Meijden, A.3
-
77
-
-
67651008250
-
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: A randomised, double-blind, placebo-controlled phase III multicentre study
-
Böhle, A. et al. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur. Urol. 56, 495-503 (2009).
-
(2009)
Eur. Urol.
, vol.56
, pp. 495-503
-
-
Böhle, A.1
-
78
-
-
36849046271
-
A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences
-
Berrum-Svennung, I., Granfors, T, Jahnson, S., Boman, H. & Holmäng, S. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. J. Urol. 179, 101-105 (2008).
-
(2008)
J. Urol.
, vol.179
, pp. 101-105
-
-
Berrum-Svennung, I.1
Granfors, T.2
Jahnson, S.3
Boman, H.4
Holmäng, S.5
-
80
-
-
41149134455
-
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer
-
Hendricksen, K. et al. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. Eur. Urol. 53, 984-991 (2008).
-
(2008)
Eur. Urol.
, vol.53
, pp. 984-991
-
-
Hendricksen, K.1
-
81
-
-
44649193794
-
Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study
-
Cai, T. et al. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J. Urol. 180, 110-115 (2008).
-
(2008)
J. Urol.
, vol.180
, pp. 110-115
-
-
Cai, T.1
-
82
-
-
67649226588
-
Treatment of nonmuscle invading bladder cancer: Do physicians in the United States practice evidence based medicine? the use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors
-
Madeb, R. et al. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115, 2660-2670 (2009).
-
(2009)
Cancer
, vol.115
, pp. 2660-2670
-
-
Madeb, R.1
-
83
-
-
77957706659
-
Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system
-
Feifer, A., Xie, X., Brophy, J. M., Segal, R. & Kassouf, W. Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system. Urology 76, 652-656 (2010).
-
(2010)
Urology
, vol.76
, pp. 652-656
-
-
Feifer, A.1
Xie, X.2
Brophy, J.M.3
Segal, R.4
Kassouf, W.5
-
84
-
-
0036668380
-
Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma
-
Kaasinen, E. et al. Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma. Eur. Urol. 42, 167-174 (2002).
-
(2002)
Eur. Urol.
, vol.42
, pp. 167-174
-
-
Kaasinen, E.1
-
85
-
-
0033888947
-
The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer
-
Solsona, E. et al. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J. Urol. 164, 685-689 (2000).
-
(2000)
J. Urol.
, vol.164
, pp. 685-689
-
-
Solsona, E.1
-
86
-
-
0036128238
-
Stage Ta-T1 bladder cancer: The relationship between findings at first followup cystoscopy and subsequent recurrence and progression
-
Holmang, S. & Johansson, S. L. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J. Urol. 167, 1634-1637 (2002).
-
(2002)
J. Urol.
, vol.167
, pp. 1634-1637
-
-
Holmang, S.1
Johansson, S.L.2
-
87
-
-
15044358608
-
A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database
-
Mariappan, P. & Smith, G. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J. Urol. 173, 1108-1111 (2005).
-
(2005)
J. Urol.
, vol.173
, pp. 1108-1111
-
-
Mariappan, P.1
Smith, G.2
-
88
-
-
33644783750
-
The management of superficial transitional cell carcinoma of the bladder
-
Sengupta, S. & Blute, M. L. The management of superficial transitional cell carcinoma of the bladder. Urology 67, 48-54 (2006).
-
(2006)
Urology
, vol.67
, pp. 48-54
-
-
Sengupta, S.1
Blute, M.L.2
-
89
-
-
0038152765
-
Expectant management of small, recurrent, noninvasive papillary bladder tumors
-
Soloway, M. S., Bruck, D. S. & Kim, S. S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J. Urol. 170, 438-441 (2003).
-
(2003)
J. Urol.
, vol.170
, pp. 438-441
-
-
Soloway, M.S.1
Bruck, D.S.2
Kim, S.S.3
-
90
-
-
32044434005
-
Watchful waiting policy in recurrent Ta G1 bladder tumors
-
Gofrit, O. N., Pode, D., Lazar, A., Katz, R. & Shapiro, A. Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur. Urol. 49, 303-307 (2006).
-
(2006)
Eur. Urol.
, vol.49
, pp. 303-307
-
-
Gofrit, O.N.1
Pode, D.2
Lazar, A.3
Katz, R.4
Shapiro, A.5
-
91
-
-
70449526272
-
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles
-
Birkhahn, M. et al. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur. Urol. 57, 12-20 (2010).
-
(2010)
Eur. Urol.
, vol.57
, pp. 12-20
-
-
Birkhahn, M.1
-
92
-
-
77951981568
-
Theranostic and prognostic biomarkers: Genomic applications in urological malignancies
-
Netto, G. J. & Epstein, J. I. Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology 42, 384-394 (2010).
-
(2010)
Pathology
, vol.42
, pp. 384-394
-
-
Netto, G.J.1
Epstein, J.I.2
-
93
-
-
39449116677
-
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
-
Bryan, R. T., Billingham, L. J. & Wallace, D. M. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int. 101, 702-705 (2008).
-
(2008)
BJU Int.
, vol.101
, pp. 702-705
-
-
Bryan, R.T.1
Billingham, L.J.2
Wallace, D.M.3
-
94
-
-
53849134494
-
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences
-
Herr, H. W. & Donat, S. M. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int. 102, 1111-1114 (2008).
-
(2008)
BJU Int.
, vol.102
, pp. 1111-1114
-
-
Herr, H.W.1
Donat, S.M.2
|